Regulation & Compliance

A new three-year agreement aims to make over 70% of Irish research free to read, but a closer look reveals the complex realities of open access.

A new VA-DOJ deal lets the government seek guardianship over veterans, but advocates warn it could strip them of their fundamental civil liberties.

A new platform, AUTOPSY, replaces security self-assessments with API-verified data, revealing a critical 'Readiness Gap' before a breach occurs.

As water infrastructure crumbles, a guide promises water from thin air. We examine the science, the hype, and if it's a real solution for your home.

The kathy ireland Worldwide brand is in crisis as its founder files a $100M lawsuit alleging decades of fraud by her managers, fracturing the empire.

Safety charges, including providing false information, laid against a Scarborough park after an 11-year-old was injured on an illegal, uninspected zipline.

A new report projects massive growth in cardiovascular devices, driven by AI and minimally invasive tech. But can the healthcare system afford this progress?

With key hires from TransUnion and Bank of America, Mutinex signals a major U.S. expansion to lead the AI-driven marketing effectiveness revolution.

As it advances its brain cancer therapies, NeOnc Technologies hires a public company finance expert to steer its next growth phase and ensure fiscal rigor.

The parent of Meineke and Maaco admits to years of accounting errors, triggering a 40% stock collapse and a class action lawsuit from angry investors.

The U.S. Center for SafeSport tests on-the-ground abuse reporting at the 2026 Games, aiming for a global safety plan for LA28 while navigating past criticism.

Aditxt's $36M acquisition of Ignite Proteomics aims to upend cancer therapy by analyzing protein activity, a high-stakes bet for the struggling innovator.

Kestrel Group reports soaring fee income from its core business, but a quarterly loss reveals the deep financial drag from its complex merger with Maiden Holdings.

Institutional Investor launches an allocator-curated 'Buy List' to benchmark private equity excellence, prioritizing transparency and governance over marketing.

With domestic production falling and global supplies at risk, experts warn a helium shortage could cripple key U.S. industries from defense to semiconductors.

The grill maker's 1-for-50 reverse stock split aims to avoid delisting, but deep financial woes and historical data suggest a tough road ahead.

A new platform merges AI, behavioral science, and global strategy, aiming to transform employee wellbeing from a perk into a core performance driver.

After a strategic pivot and R&D setbacks, Korro Bio secures an $85M lifeline to advance its novel RNA-editing drug for rare metabolic diseases.

Data shows Beren Therapeutics' drug slows progression and boosts survival for infantile-onset NPC, a rare disorder with no approved US treatments.

As CHROs lose confidence in productivity data, One Model reports record growth by offering a trusted, AI-powered people analytics infrastructure.